Literature DB >> 18765469

Kawasaki disease.

Angela M Fimbres1, Stanford T Shulman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18765469     DOI： 10.1542/pir.29-9-308

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN： 0191-9601


× No keyword cloud information.
  8 in total

1.  Concomitant respiratory viral infections in children with Kawasaki disease.

Authors:  Alejandro Jordan-Villegas; Michael L Chang; Octavio Ramilo; Asunción Mejías
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

2.  Kawasaki disease and sensorineural hearing loss: an (un)expected complication.

Authors:  Ana Novo; Susana Pinto; Ana Catarina Prior; Sílvia Alvares; Teresa Soares; Margarida Guedes
Journal:  Eur J Pediatr       Date:  2012-01-07       Impact factor: 3.183

Review 3.  Can Kawasaki disease be managed?

Authors:  Alberto Coustasse; Julius Larry; Doohee Lee
Journal:  Perm J       Date:  2012

4.  Cardiac involvement in Kawasaki disease in Pakistani children.

Authors:  Saleem Akhtar; Muhammad Matloob Alam; Mehnaz Atiq Ahmed
Journal:  Ann Pediatr Cardiol       Date:  2012-07

Review 5.  Kawasaki Disease: A Clinician's Update.

Authors:  Nathan Jamieson; Davinder Singh-Grewal
Journal:  Int J Pediatr       Date:  2013-10-27

6.  A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis.

Authors:  Jiayu Duan; Jiao Lou; Qing Zhang; Juntao Ke; Yanqi Qi; Na Shen; Beibei Zhu; Rong Zhong; Zhenling Wang; Lifeng Liu; Jing Wu; Wei Wang; Fangqi Gong; Xiaoping Miao
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

7.  Myocardial Strain and Strain Rate in Kawasaki Disease: Range, Recovery, and Relationship to Systemic Inflammation/Coronary Artery Dilation.

Authors:  Benjamin Frank; Jesse Davidson; Suhong Tong; Blake Martin; Heather Heizer; Marsha S Anderson; Mary P Glode; Samuel R Dominguez; Pei-Ni Jone
Journal:  J Clin Exp Cardiolog       Date:  2016-04-21

8.  FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.

Authors:  Daisuke Okuzaki; Kaori Ota; Shin-Ichi Takatsuki; Yukari Akiyoshi; Kazuyuki Naoi; Norikazu Yabuta; Tsutomu Saji; Hiroshi Nojima
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.